Casodex/Zoladex Hormonal therApy study for assessMent of correlation between PSA & BAI in prOstate cancer patieNts - CHAMPION

Study identifier:NIS-OKR-CAS-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An observational study to assess correlation between Prostate Specific Antigen & Beck Anxiety Index in prostate cancer patients under hormonal therapy

Medical condition

prostate cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Male

Actual Enrollment

1200

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 May 2007
Primary Completion Date: 01 Nov 2008
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria